Menu

Question 2021

Topic: Biology, Genetics & Bone Healing

An 18-month-old child presents with severe clinical and radiographic signs of rickets, accompanied by total body alopecia. Laboratory evaluation reveals hypocalcemia, hypophosphatemia, and markedly elevated levels of 1,25-dihydroxyvitamin D. What is the most likely diagnosis?

. X-linked hypophosphatemic rickets
. Vitamin D-dependent rickets type I
. Vitamin D-dependent rickets type II
. Hypophosphatasia
. Nutritional rickets

Correct Answer & Explanation

. Vitamin D-dependent rickets type II


Explanation

Vitamin D-dependent rickets type II is caused by an end-organ resistance to active vitamin D due to a mutation in the Vitamin D Receptor (VDR). It is characterized by profoundly elevated 1,25-dihydroxyvitamin D levels and the classic clinical finding of total body alopecia.

Question 2022

Topic: Biology, Genetics & Bone Healing

A 65-year-old man presents with progressive anterior bowing of his right tibia and states his hats no longer fit. Biopsy of the affected bone reveals a mosaic pattern of lamellar bone with prominent cement lines. What is the primary initiating cellular event in the pathogenesis of this disease?

. Excessive osteoblast proliferation
. Deficient osteoid mineralization
. Markedly increased osteoclastic bone resorption
. Malignant transformation of osteoprogenitor cells
. Deposition of unmineralized osteoid

Correct Answer & Explanation

. Markedly increased osteoclastic bone resorption


Explanation

Paget's disease of bone occurs in three phases: an initial lytic phase, a mixed phase, and a sclerotic phase. The primary inciting event is a massive increase in osteoclastic bone resorption, followed by a frantic and disorganized osteoblastic response.

Question 2023

Topic: Biology, Genetics & Bone Healing

A newborn presents with severe anterior bowing of the lower extremities, hypoplastic scapulae, and respiratory distress due to tracheobronchomalacia. Genetic testing reveals a 46,XY karyotype, but the infant has unambiguous phenotypic female genitalia. A mutation in which gene is responsible for this condition?

. FGFR3
. SOX9
. COL1A1
. RUNX2
. COMP

Correct Answer & Explanation

. SOX9


Explanation

Campomelic dysplasia is an autosomal dominant condition caused by a mutation in the SOX9 gene. It is characterized by severe bowing of the long bones, respiratory distress from tracheomalacia, and sex reversal (phenotypic females with XY karyotype).

Question 2024

Topic: Biology, Genetics & Bone Healing

A 14-month-old child fed exclusively on boiled cow's milk presents with extreme irritability, bleeding gums, and painful, swollen lower extremities. Radiographs show a dense zone of provisional calcification (white line of Frankel) and a radiolucent band directly beneath it (Trummerfeld zone). What specific biochemical process is impaired in this patient?

. Gamma-carboxylation of glutamic acid residues
. Hydroxylation of proline and lysine residues
. Cleavage of type I procollagen
. Cross-linking of collagen via lysyl oxidase
. Proton pump activity in the osteoclast ruffled border

Correct Answer & Explanation

. Hydroxylation of proline and lysine residues


Explanation

The patient has scurvy due to Vitamin C deficiency. Vitamin C is a crucial cofactor for prolyl and lysyl hydroxylase; its absence prevents the hydroxylation of proline and lysine residues, leading to unstable collagen triple helices and capillary fragility.

Question 2025

Topic: Biology, Genetics & Bone Healing

A 3-year-old boy presents with progressive bilateral bowing of his legs and a waddling gait. Laboratory studies reveal normal serum calcium, markedly decreased serum phosphate, normal PTH, and elevated alkaline phosphatase. Genetic testing confirms a mutation in the PHEX gene. Which of the following best describes the underlying pathophysiology?

. Decreased renal reabsorption of phosphate due to elevated FGF-23
. Impaired 1-alpha-hydroxylase activity in the kidney due to PTH deficiency
. Autoimmune destruction of parathyroid glands
. Defective tissue-nonspecific alkaline phosphatase activity
. Impaired intestinal absorption of calcium leading to secondary hyperparathyroidism

Correct Answer & Explanation

. Decreased renal reabsorption of phosphate due to elevated FGF-23


Explanation

X-linked hypophosphatemic rickets is caused by a PHEX mutation leading to excess FGF-23. Elevated FGF-23 inhibits renal phosphate reabsorption and 1-alpha-hydroxylase, resulting in phosphaturia and severe rickets despite normal calcium levels.

Question 2026

Topic: Biology, Genetics & Bone Healing

A 3-year-old child with a history of recurrent fractures is initiated on cyclic intravenous pamidronate therapy.

What is the primary cellular mechanism of action of this medication?

. Stimulation of osteoblast differentiation and bone formation
. Inhibition of osteoclast function by disrupting the mevalonate pathway
. Direct binding and neutralization of RANK-ligand (RANKL)
. Blockade of the calcium-sensing receptor on parathyroid cells
. Enhancement of intestinal calcium and phosphate absorption

Correct Answer & Explanation

. Inhibition of osteoclast function by disrupting the mevalonate pathway


Explanation

Nitrogen-containing bisphosphonates (like pamidronate) inhibit farnesyl pyrophosphate synthase in the mevalonate pathway. This impairs osteoclast function, reduces bone resorption, and improves bone mineral density in osteogenesis imperfecta.

Question 2027

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with knee pain. Radiographs show an eccentric, lytic epiphyseal-metaphyseal lesion of the distal femur extending to the subchondral bone. Biopsy shows multinucleated giant cells in a background of mononuclear stroma. Before surgical curettage, the multidisciplinary team recommends a targeted medical therapy. What is the mechanism of action of the most commonly used agent?

. Inhibition of vascular endothelial growth factor (VEGF)
. Monoclonal antibody binding to RANK ligand (RANKL)
. Inhibition of the mTOR pathway
. Binding to the CD20 antigen
. Cross-linking of DNA

Correct Answer & Explanation

. Monoclonal antibody binding to RANK ligand (RANKL)


Explanation

Giant Cell Tumor (GCT) of bone is often treated with denosumab, a monoclonal antibody that binds to RANKL, inhibiting the differentiation and activation of osteoclast-like giant cells. This is particularly useful for downsizing tumors near articular surfaces prior to surgery.

Question 2028

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman presents with knee pain. Radiographs show an eccentric, purely lytic epiphyseal lesion in the distal femur extending precisely to the subchondral bone plate. A biopsy reveals multinucleated giant cells within a stroma of mononuclear cells. Which targeted therapy is most appropriate for locally advanced, unresectable cases of this tumor?

. Imatinib
. Denosumab
. Zoledronic acid
. Rituximab
. Pembrolizumab

Correct Answer & Explanation

. Denosumab


Explanation

The diagnosis is a Giant Cell Tumor of bone. Denosumab, a monoclonal antibody against RANKL, prevents the maturation and activation of osteoclasts and the multinucleated giant cells, making it the primary medical treatment for unresectable cases.

Question 2029

Topic: Biology, Genetics & Bone Healing

A 65-year-old man presents with generalized back pain, fatigue, and hypercalcemia. A skeletal survey demonstrates multiple "punched-out" lytic lesions in the skull and spine. Serum protein electrophoresis reveals a monoclonal IgG spike. What specific cell type is primarily responsible for the bone resorption seen in this disease process?

. Malignant plasma cells
. Osteoblasts
. Osteoclasts
. Macrophages
. T-lymphocytes

Correct Answer & Explanation

. Osteoclasts


Explanation

In multiple myeloma, the lytic bone lesions are caused by marked osteoclast activation, not direct destruction by tumor cells. Malignant plasma cells secrete factors (like RANKL and MIP-1a) that upregulate osteoclast activity while suppressing osteoblasts.

Question 2030

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with knee pain. Radiographs reveal an eccentric, lytic, epiphyseal lesion in the proximal tibia extending to the subchondral bone. Biopsy shows multinucleated giant cells in a background of mononuclear stromal cells. Which targeted therapy is most appropriate if the lesion is deemed unresectable?

. Imatinib
. Denosumab
. Rituximab
. Infliximab
. Zoledronic acid

Correct Answer & Explanation

. Denosumab


Explanation

Giant cell tumors of bone consist of neoplastic mononuclear stromal cells that express RANKL, which recruits reactive osteoclast-like giant cells causing osteolysis. Denosumab, a monoclonal RANKL inhibitor, is highly effective for downstaging or managing unresectable disease.

Question 2031

Topic: Biology, Genetics & Bone Healing

A 70-year-old man presents with increasing hat size, hearing loss, and bowing of the tibiae. Laboratory tests show markedly elevated serum alkaline phosphatase but normal calcium and phosphorus levels. What is the primary cellular defect in the initial phase of this disease?

. Overactive osteoblasts producing disorganized woven bone
. Abnormal, hypernucleated osteoclasts with excessive resorptive activity
. Impaired mineralization of osteoid secondary to vitamin D deficiency
. Defective type I collagen synthesis
. Accumulation of unmineralized matrix at the growth plate

Correct Answer & Explanation

. Abnormal, hypernucleated osteoclasts with excessive resorptive activity


Explanation

Paget's disease initiates with a chaotic, intense osteoclastic resorption phase driven by abnormal, hypernucleated osteoclasts. This is subsequently followed by a rapid, disorganized osteoblastic response forming weak woven bone.

Question 2032

Topic: Biology, Genetics & Bone Healing

A 65-year-old woman presents with severe, progressive back pain. Radiographs show multiple "punched-out" lytic lesions in the skull and vertebrae. Serum protein electrophoresis shows an M-spike. Which pathway is primarily responsible for the prominent osteolytic lesions seen in this condition?

. Upregulation of BMP-2 by plasma cells
. Direct bone resorption by malignant plasma cells
. Myeloma cell-induced upregulation of RANKL and downregulation of OPG
. Excessive IL-10 secretion suppressing osteoblasts
. Overproduction of Osteoprotegerin (OPG)

Correct Answer & Explanation

. Myeloma cell-induced upregulation of RANKL and downregulation of OPG


Explanation

Multiple myeloma cells secrete factors (such as MIP-1 alpha and IL-6) that upregulate RANKL expression on osteoblasts and simultaneously downregulate OPG. This severe imbalance leads to massive osteoclast activation and characteristic lytic bone destruction.

Question 2033

Topic: Biology, Genetics & Bone Healing

A 3-year-old boy presents with severe bowing of the legs and short stature. Labs show normal serum calcium, very low serum phosphorus, normal PTH, and elevated alkaline phosphatase. Genetic testing reveals a mutation in the PHEX gene. What is the core pathophysiology of this specific disease?

. Deficiency of 1-alpha-hydroxylase in the kidney
. Resistance to Vitamin D at the receptor level
. Excess production of FGF-23 leading to renal phosphate wasting
. Autoimmune destruction of parathyroid glands
. Impaired intestinal absorption of dietary calcium

Correct Answer & Explanation

. Excess production of FGF-23 leading to renal phosphate wasting


Explanation

X-linked hypophosphatemic rickets is caused by a PHEX mutation, which ultimately leads to the unregulated overproduction of FGF-23. Elevated FGF-23 strongly inhibits renal phosphate reabsorption, causing profound hypophosphatemia and defective bone mineralization.

Question 2034

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with a lytic epiphyseal lesion of the proximal tibia. Biopsy confirms Giant Cell Tumor (GCT). For an unresectable lesion, which pharmacologic agent is most specifically targeted to the pathophysiology of this tumor?

. Imatinib
. Denosumab
. Methotrexate
. Doxorubicin
. Teriparatide

Correct Answer & Explanation

. Denosumab


Explanation

Denosumab is a monoclonal antibody against RANKL. It inhibits the recruitment and activation of osteoclast-like giant cells in GCT, causing ossification and tumor stabilization.

Question 2035

Topic: Biology, Genetics & Bone Healing

A 12-year-old patient presents with multiple cafe-au-lait spots, axillary freckling, and Lisch nodules.

The genetic mutation responsible for this condition affects a protein that normally acts as a:

. Constitutively active tyrosine kinase
. Tumor suppressor gene acting as a GTPase-activating protein
. Defective transmembrane RANK receptor
. Mutated transcription factor in the Wnt pathway
. Aberrant structural collagen type I

Correct Answer & Explanation

. Tumor suppressor gene acting as a GTPase-activating protein


Explanation

Neurofibromatosis type 1 is caused by a mutation in the NF1 gene on chromosome 17, which encodes neurofibromin. Neurofibromin is a GTPase-activating protein (GAP) that normally downregulates Ras; its loss leads to uncontrolled cellular proliferation.

Question 2036

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with a destructive, eccentrically located epiphyseal lesion in the distal femur. Biopsy confirms a Giant Cell Tumor (GCT). If medical therapy with Denosumab is initiated, what is the specific cellular target of this drug?

. It inhibits the RANK receptor directly on multinucleated giant cells
. It binds to RANKL secreted by the neoplastic stromal cells
. It directly induces apoptosis of the neoplastic giant cells
. It stimulates osteoprotegerin (OPG) production by osteoblasts
. It acts as a bisphosphonate binding to bone hydroxyapatite

Correct Answer & Explanation

. It binds to RANKL secreted by the neoplastic stromal cells


Explanation

Denosumab is a monoclonal antibody that specifically binds to RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand), which is secreted by the neoplastic mononuclear stromal cells in GCT. By neutralizing RANKL, it prevents the recruitment and activation of osteoclast-like giant cells.

Question 2037

Topic: Biology, Genetics & Bone Healing

A 65-year-old man presents with progressive bowing of his tibiae and an increasing hat size. Laboratory tests reveal an isolated, markedly elevated alkaline phosphatase. A bone biopsy during the late phase of this disease would most likely show:

. Irregular woven bone lacking osteoblastic rimming
. A mosaic pattern of lamellar bone with prominent cement lines
. Thickened trabeculae with empty lacunae
. Nests of atypical plasma cells in the marrow space
. Spindle cells in a storiform pattern with foamy macrophages

Correct Answer & Explanation

. A mosaic pattern of lamellar bone with prominent cement lines


Explanation

The patient has Paget's disease of bone. The histologic hallmark of the late (sclerotic/mixed) phase is a 'mosaic pattern' of lamellar bone with haphazard, prominent cement lines resulting from chaotic cycles of bone resorption and formation.

Question 2038

Topic: Biology, Genetics & Bone Healing

A patient with end-stage renal disease (ESRD) presents with diffuse bone pain. Labs show hypocalcemia, hyperphosphatemia, and severely elevated Parathyroid Hormone (PTH) levels. The primary underlying defect causing impaired bone mineralization in this patient is a deficiency of:

. Dietary calcium intake
. 25-hydroxylase activity in the liver
. 1-alpha-hydroxylase activity in the kidney
. Calcitonin production by the thyroid
. Alkaline phosphatase activity in osteoblasts

Correct Answer & Explanation

. 1-alpha-hydroxylase activity in the kidney


Explanation

In renal osteodystrophy, the failing kidneys lose 1-alpha-hydroxylase activity, preventing the conversion of 25-hydroxyvitamin D to active 1,25-dihydroxyvitamin D. This leads to decreased intestinal calcium absorption, hypocalcemia, and severe secondary hyperparathyroidism.

Question 2039

Topic: Biology, Genetics & Bone Healing
A 2-year-old boy presents with anterolateral bowing of the tibia and multiple café-au-lait macules. Radiographs demonstrate thinning of the tibial cortex and impending fracture. What is the normal physiologic function of the protein encoded by the mutated gene responsible for this condition?
. Stimulates osteoblast differentiation
. Downregulates Ras signaling
. Forms the type I collagen triple helix
. Inhibits matrix metalloproteinases
. Promotes FGF receptor signaling

Correct Answer & Explanation

. Downregulates Ras signaling


Explanation

Neurofibromatosis type 1 is caused by a mutation in the NF1 gene on chromosome 17, which encodes neurofibromin. Neurofibromin acts as a GTPase-activating protein that downregulates Ras signaling; its absence leads to hyperactive Ras and subsequent tissue dysplasia.

Question 2040

Topic: Biology, Genetics & Bone Healing

A 32-year-old woman presents with a lytic lesion in the distal femur extending into the subchondral bone. Biopsy confirms a Giant Cell Tumor of bone. She is treated with denosumab preoperatively to consolidate the tumor margins. What is the exact mechanism of action of this medication?

. Inhibits osteoclast H+/K+ ATPase
. Directly induces apoptosis in neoplastic stromal cells
. Binds to and inhibits RANK ligand
. Inhibits vascular endothelial growth factor (VEGF)
. Agonizes the calcium-sensing receptor

Correct Answer & Explanation

. Binds to and inhibits RANK ligand


Explanation

Denosumab is a monoclonal antibody that targets and binds to RANKL, preventing it from binding to the RANK receptor on osteoclasts. This effectively inhibits osteoclast differentiation and function, targeting the reactive multinucleated giant cells characteristic of the tumor.